Error message
Notice: Undefined index: content in _drupal_default_html_head() (line 345 of /var/www/vhosts/rovi.es/httpdocs/includes/common.inc).
|
Date |
Title |
Description |
PDF |
|
10 May 2023 |
On P&L |
The Company releases the first quarter 2023 financial results presentation
|
Download |
|
10 May 2023 |
On P&L |
The Company releases the press release related to the first quarter 2023 financial results
|
Download |
|
25 Apr 2023 |
On business and financial situation |
ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE)
|
Download |
|
21 Feb 2023 |
About Corporate Governance |
The Company informs about the agreements adopted by the Board of Directors
|
Download |
|
21 Feb 2023 |
On business and financial situation |
The Company releases the full year 2022 financial results presentation.
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
17 Dec 2021 |
On business and financial situation |
ROVI reports that the CHMP has issued a positive opinion on Okedi® for the treatment for schizophrenia
|
Download |
|
13 Dec 2021 |
Share buy-back , stabilisation and treasury stock programmes |
Share Buyback Program: transactions conducted between 6 December 2021 and 10 December 2021
|
Download |
|
06 Dec 2021 |
Share buy-back , stabilisation and treasury stock programmes |
Share Buyback Program: transactions conducted between 29 November 2021 and 3 December 2021
|
Download |
|
22 Nov 2021 |
Share buy-back , stabilisation and treasury stock programmes |
Share Buyback Program: transactions conducted between 15 November 2021 and 19 November 2021
|
Download |
|
16 Nov 2021 |
Liquidity and counterparty agreements |
The Company informs of the termination of the Liquidity Agreement
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
26 Feb 2019 |
Información sobre resultados |
ROVI releases the presentation related to the full year 2018 results
|
Download |
|
26 Feb 2019 |
Información sobre resultados |
ROVI releases the press release related to the full year 2018 results
|
Download |
|
15 Feb 2019 |
Others on business performance and financial information |
ROVI acquires rights to Dexchlorpheniramine Maleate in the Spanish and French markets
|
Download |
|
09 Jan 2019 |
Others on business performance and financial information |
ROVI informs about the adquisition of Falithrom® for the German market
|
Download |
|
08 Jan 2019 |
Liquidity contracts and specialists |
Liquidity contract: transactions conducted in the fourth quarter of 2018
|
Download |
Pages
